These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14269256)

  • 1. PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS.
    SIMON J
    Arch Gesamte Virusforsch; 1965; 15():220-33. PubMed ID: 14269256
    [No Abstract]   [Full Text] [Related]  

  • 2. [EVALUATION OF NEURAL LESIONS IN MONKEYS INOCULATED WITH SABIN POLIOVIRUS VACCINE].
    LUSSIER G; PAVILANIS V; DIFRANCO E
    Rev Can Biol; 1964 Sep; 23():323-32. PubMed ID: 14237165
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE NEUROVIRULENCE TEST OF LIVE POLIOVIRUS VACCINES. I. BASES, TECHNIC AND EVALUATION OF THE RESEARCH ON NEUROVIRULENCE MEASUREMENT IN MONKEYS].
    BONIN O; UNTERHARNSCHEIDT F
    Arch Psychiatr Nervenkr; 1964 Nov; 206():260-71. PubMed ID: 14344120
    [No Abstract]   [Full Text] [Related]  

  • 4. NEUROVIRULENCE FOR MONKEYS OF SABIN'S TYPE 1 POLIOVIRUS PASSED THROUGH HUMAN INTESTINES AS COMPARED WITH ATTENUATED AND VIRULENT POLIOVIRUS STRAINS.
    SIMON J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():506-15. PubMed ID: 14238949
    [No Abstract]   [Full Text] [Related]  

  • 5. THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
    VONKA V; JANDA Z; SIMON J
    Arch Gesamte Virusforsch; 1964 Jun; 14():599-610. PubMed ID: 14247356
    [No Abstract]   [Full Text] [Related]  

  • 6. A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES.
    PAVILANIS V; LUSSIER G; FOLEY AR; CHARBONNEAU JH; DIFRANCO E; DUBREUIL R
    Rev Can Biol; 1964 Sep; 23():265-76. PubMed ID: 14237159
    [No Abstract]   [Full Text] [Related]  

  • 7. PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. 3. A SMALL SCALE TRIAL WITH USOL-D BAC VIRUS IN A CLOSED CHILD COMMUNITY.
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H; STAREK M
    Arch Gesamte Virusforsch; 1965; 15():234-43. PubMed ID: 14269257
    [No Abstract]   [Full Text] [Related]  

  • 8. Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract.
    Simon J; Vonka V; Janda Z
    Arch Gesamte Virusforsch; 1965; 15(5):681-9. PubMed ID: 4285635
    [No Abstract]   [Full Text] [Related]  

  • 9. LYOPHILIZATION OF ENTEROVIRUSES.
    GEORGE S; GHARPURE PV
    Indian J Pathol Bacteriol; 1964 Jan; 10():46-53. PubMed ID: 14114752
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].
    UNTERHARNSCHEIDT F; BONIN O
    Arch Psychiatr Nervenkr; 1965 Mar; 206():454-73. PubMed ID: 14271779
    [No Abstract]   [Full Text] [Related]  

  • 11. CHARACTERISTICS OF SABIN TYPE 1 POLIOVIRUS AFTER GASTROINTESTINAL PASSAGE IN NEWBORN INFANTS. II. ANTIGENICITY AND ELUTION FROM AL(OH)3 GEL.
    WOODS WA; ROBBINS FC; WEISS RA; CASHEL J; KIRSCHSTEIN RL
    Am J Hyg; 1964 Mar; 79():236-44. PubMed ID: 14131876
    [No Abstract]   [Full Text] [Related]  

  • 12. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 13. ON THE NEUROVIRULENCE OF POLIOVIRUS.
    UCHIDA N
    Jpn J Med Sci Biol; 1963 Jun; 16():132-5. PubMed ID: 14048399
    [No Abstract]   [Full Text] [Related]  

  • 14. PHOSPHATASE ACTIVITY IN HOMOGENATES FROM NORMAL AND POLIOVIRUS INFECTED TISSUE CULTURES. II. VARIATIONS INDUCED BY INFECTION AND BICARBONATE POISONING.
    DEIG EF; GEBHARDT LP
    Z Naturforsch B; 1963 Nov; 18():912-8. PubMed ID: 14101865
    [No Abstract]   [Full Text] [Related]  

  • 15. [WHAT DOES THE TESTING OF VIRAL VACCINES DO FOR THE HARMLESSNESS OF VACCINES IN THEIR PRACTICAL USE?].
    BONIN O; GUENTHER O
    Med Welt; 1964 Apr; 15():822-31. PubMed ID: 14194499
    [No Abstract]   [Full Text] [Related]  

  • 16. [CLINICAL AND ELECTROENCEPHALOGRAPHIC FINDINGS ON PSYCHO-ORGANIC MANIFESTATIONS NOTED IN CHILDREN VACCINATED WITH LIVE ATTENUATED SABIN POLIOVIRUS VACCINE].
    LOPERFIDO E; ANCONA A; PIERALISI G
    Clin Pediatr (Bologna); 1964 Jun; 46():SUPPL:89-99. PubMed ID: 14276643
    [No Abstract]   [Full Text] [Related]  

  • 17. MARKER TEST OF POLIOVIRUS IN RELATION TO MASS VACCINATION WITH LIVE ORAL VACCINES.
    TOYOSHIMA K; MITSUDA B; TADOKORO J; YAMADA T; KUNITA N
    Biken J; 1963 Jul; 6():57-72. PubMed ID: 14147706
    [No Abstract]   [Full Text] [Related]  

  • 18. RESULTS OF INVESTIGATION OF TYPE 1 VIRUSES ISOLATED FROM PARALYTIC PATIENTS IN THE PERIOD FOLLOWING MASS VACCINATION WITH SABIN'S VACCINE IN CZECHOSLOVAKIA IN 1960.
    VONKA V; JANDA Z; SIMON J; ADAM E; ZAVADOVA H
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():58-76. PubMed ID: 14128980
    [No Abstract]   [Full Text] [Related]  

  • 19. [POLIOMYELITIS IN THE CHILD. REFERENCES TO VIROLOGICAL FINDINGS].
    GONZALEZ M; SCROGGIE S; DIAZ R
    Rev Chil Pediatr; 1964 Jan; 35():24-8. PubMed ID: 14163294
    [No Abstract]   [Full Text] [Related]  

  • 20. [VIROLOGICAL STUDIES ON 2 PATIENTS WITH PARESIS IN CHRONOLOGICAL RELATION TO VACCINATION WITH ORAL POLIOVACCINE IN APRIL-MAY 1963].
    HAHNEMANN F; SIBONI K; GODTFREDSEN A; VON MAGNUS
    Fra Sundhedsstyr; 1963 Oct; 125():72-3. PubMed ID: 14095905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.